Role of vaccination in patients with human monkeypox virus and its cardiovascular manifestations
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc..
Human monkeypox, caused by the monkeypox virus (MPXV), is an emerging infectious disease with the potential for human-to-human transmission and diverse clinical presentations. While generally considered milder than smallpox, it can lead to severe cardiovascular complications. The virus primarily spreads through contact with infected animals or through human-to-human transmission. Cardiovascular involvement in human monkeypox is rare but has been associated with myocarditis, pericarditis, arrhythmias, and even fulminant myocardial infarction. Vaccination plays a crucial role in preventing and controlling monkeypox, but the eradication of smallpox has left global populations vulnerable. This review explores the cardiovascular manifestations of human monkeypox, the role of vaccination in disease prevention, and the importance of continued research and development of effective vaccines to protect against this emerging infectious threat. The global impact of monkeypox outbreaks, particularly on vulnerable populations, further highlights the importance of understanding and addressing this disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:86 |
---|---|
Enthalten in: |
Annals of medicine and surgery (2012) - 86(2024), 3 vom: 14. März, Seite 1506-1516 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Maqbool, Khawaja Usama [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiovascular manifestations |
---|
Anmerkungen: |
Date Revised 12.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1097/MS9.0000000000001674 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369528638 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369528638 | ||
003 | DE-627 | ||
005 | 20240312234241.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240311s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/MS9.0000000000001674 |2 doi | |
028 | 5 | 2 | |a pubmed24n1324.xml |
035 | |a (DE-627)NLM369528638 | ||
035 | |a (NLM)38463133 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Maqbool, Khawaja Usama |e verfasserin |4 aut | |
245 | 1 | 0 | |a Role of vaccination in patients with human monkeypox virus and its cardiovascular manifestations |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.03.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. | ||
520 | |a Human monkeypox, caused by the monkeypox virus (MPXV), is an emerging infectious disease with the potential for human-to-human transmission and diverse clinical presentations. While generally considered milder than smallpox, it can lead to severe cardiovascular complications. The virus primarily spreads through contact with infected animals or through human-to-human transmission. Cardiovascular involvement in human monkeypox is rare but has been associated with myocarditis, pericarditis, arrhythmias, and even fulminant myocardial infarction. Vaccination plays a crucial role in preventing and controlling monkeypox, but the eradication of smallpox has left global populations vulnerable. This review explores the cardiovascular manifestations of human monkeypox, the role of vaccination in disease prevention, and the importance of continued research and development of effective vaccines to protect against this emerging infectious threat. The global impact of monkeypox outbreaks, particularly on vulnerable populations, further highlights the importance of understanding and addressing this disease | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Cardiovascular manifestations | |
650 | 4 | |a human monkeypox | |
650 | 4 | |a infectious disease | |
650 | 4 | |a monkeypox virus | |
650 | 4 | |a vaccination emerging | |
700 | 1 | |a Akhtar, Muhammad Talha |e verfasserin |4 aut | |
700 | 1 | |a Ayub, Shayan |e verfasserin |4 aut | |
700 | 1 | |a Simran, Fnu |e verfasserin |4 aut | |
700 | 1 | |a Malik, Jahanzeb |e verfasserin |4 aut | |
700 | 1 | |a Malik, Maria |e verfasserin |4 aut | |
700 | 1 | |a Zubair, Rafia |e verfasserin |4 aut | |
700 | 1 | |a Mehmoodi, Amin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of medicine and surgery (2012) |d 2012 |g 86(2024), 3 vom: 14. März, Seite 1506-1516 |w (DE-627)NLM245154396 |x 2049-0801 |7 nnns |
773 | 1 | 8 | |g volume:86 |g year:2024 |g number:3 |g day:14 |g month:03 |g pages:1506-1516 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/MS9.0000000000001674 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 86 |j 2024 |e 3 |b 14 |c 03 |h 1506-1516 |